The Impact of GLP-1RA and SGLT2i on CKD Progression in Subjects with Diabetes | Peter Rossing, MD

  Рет қаралды 264

Renal Research Institute

Renal Research Institute

Күн бұрын

Пікірлер
Obesity as a risk factor of CKD progression: is there a role for GLP-1RA? | Peter Rossing, MD
26:35
Obesity as a risk factor of CKD progression: is there a role for GLP-1RA? | Peter Rossing, MD
Renal Research Institute
Рет қаралды 336
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
34:04
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
The Texas Heart Institute
Рет қаралды 4,3 М.
Jaidarman TOP / Жоғары лига-2023 / Жекпе-жек 1-ТУР / 1-топ
1:30:54
Jaidarman TOP / Жоғары лига-2023 / Жекпе-жек 1-ТУР / 1-топ
Jaidarman OFFICIAL / JCI
Рет қаралды 188 М.
Төреғали Төреәлі - Қай жақсылығым үшін? (MOOD VIDEO)
3:17
Төреғали Төреәлі - Қай жақсылығым үшін? (MOOD VIDEO)
Toregali Toreali
Рет қаралды 140 М.
Who is More Stupid? #tiktok #sigmagirl #funny
0:27
Who is More Stupid? #tiktok #sigmagirl #funny
CRAZY GREAPA
Рет қаралды 10 МЛН
The Lost World: Living Room Edition
0:46
The Lost World: Living Room Edition
Daniel LaBelle
Рет қаралды 27 МЛН
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In
15:34
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In
Medscape
Рет қаралды 11 М.
Roundtable: Preventing CKD progression: what will the future bring? I Moderator: Peter Rossing, MD
9:10
Roundtable: Preventing CKD progression: what will the future bring? I Moderator: Peter Rossing, MD
Renal Research Institute
Рет қаралды 100
Fundamentals of SGLT2i's and GLP-1RA's for CV Risk
14:53
Fundamentals of SGLT2i's and GLP-1RA's for CV Risk
American College of Cardiology
Рет қаралды 1,6 М.
Free CME Opportunity! Filtering Out the Potential Role of SGLT2 Inhibitors for the Management of CKD
52:59
Free CME Opportunity! Filtering Out the Potential Role of SGLT2 Inhibitors for the Management of CKD
ACOIorg
Рет қаралды 92
Diabetes 13, Hypoglycaemia
11:22
Diabetes 13, Hypoglycaemia
Dr. John Campbell
Рет қаралды 32 М.
GLP-1 RA Therapy in T2D - Vinni Makin, MD, Kevin M. Pantalone, DO, Pratibha PR Rao, MD, MPH
37:17
GLP-1 RA Therapy in T2D - Vinni Makin, MD, Kevin M. Pantalone, DO, Pratibha PR Rao, MD, MPH
ClevelandClinicCME
Рет қаралды 749
Navigating the GLP-1 Revolution: A Doctor's Perspective on Ozempic, Wegovy, and Mounjaro
33:30
Navigating the GLP-1 Revolution: A Doctor's Perspective on Ozempic, Wegovy, and Mounjaro
Dr. Daniel Stickler - Life Of Excellence Podcast
Рет қаралды 174
Webinar on "Going with the FLOW - GLP-1 Agonist use in Kidney Disease"
1:11:32
Webinar on "Going with the FLOW - GLP-1 Agonist use in Kidney Disease"
NephroPlus Dialysis Centres
Рет қаралды 604
CKD progression and its prevention: the practical use of GLP-1RA and SGLT2i I Thomas Ebert. MD
32:52
CKD progression and its prevention: the practical use of GLP-1RA and SGLT2i I Thomas Ebert. MD
Renal Research Institute
Рет қаралды 433
GLP 1, Mounjaro, Wegovy & Ozempic: How These Affect Weight Loss & Metabolic Health | Dr. Rob Lustig
50:48
GLP 1, Mounjaro, Wegovy & Ozempic: How These Affect Weight Loss & Metabolic Health | Dr. Rob Lustig
Levels
Рет қаралды 268 М.
Jaidarman TOP / Жоғары лига-2023 / Жекпе-жек 1-ТУР / 1-топ
1:30:54
Jaidarman TOP / Жоғары лига-2023 / Жекпе-жек 1-ТУР / 1-топ
Jaidarman OFFICIAL / JCI
Рет қаралды 188 М.